Literature DB >> 24692532

Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort.

Shigeki Momohara1, Eisuke Inoue, Katsunori Ikari, Kensuke Ochi, Osamu Ishida, Koichiro Yano, Yu Sakuma, Shinji Yoshida, Takuma Koyama, Naoko Koenuma, Atsuo Taniguchi, Hisashi Yamanaka.   

Abstract

OBJECTIVE: To describe current trends in the numbers of rheumatoid arthritis (RA)-related surgeries.
METHODS: The number of operations was determined for patients with RA in a large observational cohort [Institute of Rheumatology, Rheumatoid Arthritis (IORRA)] enrolled from 2001 to 2012.
RESULTS: The total number of operations peaked in 2002 and gradually decreased thereafter, but began to increase again in 2008. The number of total knee replacements has decreased since 2003, while the number of wrist and foot arthroplasties and the number of artificial finger prosthesis surgeries have increased gradually.
CONCLUSION: Our results suggest that the number of orthopedic surgeries may change in response to changes in the drug therapy for RA.

Entities:  

Keywords:  BIOLOGICS; DISEASE-MODIFYING ANTIRHEUMATIC DRUGS; ORTHOPEDIC JOINT SURGERY; RHEUMATOID ARTHRITIS

Mesh:

Substances:

Year:  2014        PMID: 24692532     DOI: 10.3899/jrheum.131018

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care.

Authors:  Steven J Girdler; Ivan Ye; Ray Tang; Noah Kirschner
Journal:  J Orthop       Date:  2019-07-01

2.  Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study.

Authors:  Yosuke Hamamoto; Hiromu Ito; Moritoshi Furu; Motomu Hashimoto; Takao Fujii; Masahiro Ishikawa; Noriyuki Yamakawa; Chikashi Terao; Masayuki Azukizawa; Takahiro Iwata; Tsuneyo Mimori; Shuichi Matsuda
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.